Liquid Biopsy in Breast Cancer: Clinical Implications of ctDNA and CTCs in Diagnosis, Treatment, and Monitoring

Liquid biopsies for cancer come with trade-offs

Will liquid biopsies transform cancer care? Moderator: Liz Szabo, independent journalist Jared Fischer, assistant professor of molecular genetics, Oregon Health & Science University Jose Montoya Mira, translational scientist and bioengineer, Oregon Health & Science University Jasmine Zhou, professor of pathology and laboratory medicine, University of California, Los Angeles By David Wahlberg, Wisconsin Health Journalism Fellowship Developing “…

Liquid Biopsy in Breast Cancer: Clinical Implications of ctDNA and CTCs in Diagnosis, Treatment, and Monitoring

The authors focus on the clinical applications of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in breast cancer progression, relapse, diagnosis, and treatment response. [Molecular and Cellular Biochemistry] Abstract